Download PDF version

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Sociality and disease transmission wikipedia , lookup

Neonatal infection wikipedia , lookup

Hepatitis B wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Marburg virus disease wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Germ theory of disease wikipedia , lookup

Globalization and disease wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Infection wikipedia , lookup

Infection control wikipedia , lookup

Transcript
Published on National Health and Medical Research Council (https://www.nhmrc.gov.au)
Generated on 6 May 2017 @ 7:28pm
Appendix 1: Membership and Terms of Reference of the Working
Committee
Members
Affiliation
Area of expertise
Dr Ann Koehler
(Chair)
Director, Communicable Disease Control Branch, SA Health
Clinical microbiology, communicable disease
control, epidemiology
Prof Chris
Baggoley
Chief Executive Officer of the Australian Commission on Safety and
Quality in Healthcare
Safety and quality in healthcare
Clinical Prof Keryn
Christiansen
Clinical Microbiologist, PathWest Laboratory Medicine, Royal Perth
Hospital WA
Microbiology, infectious diseases,
antimicrobial resistance and surveillance
Dr Liz Coates
Senior Consultant, Adelaide Dental Hospital. ADA representative
Infection control in dental settings
Professor Peter
Collignon
Infectious diseases physician and microbiologist
Antibiotic resistance and infection control in
hospitals
Director, Infectious Diseases Unit and Microbiology Department, The
Canberra Hospital.
Professor, School of Clinical Medicine, Australian National University,
ACT
Dr Celia Cooper
Director, Microbiology and Infectious Diseases, Children’s, Youth and
Women’s Health Service, Adelaide
Infectious diseases, public health, and
medicine
Dr Nick Demediuk
General Practitioner, Royal Australian College of General
Practitioners
General practice, infection control in office
based practice
Dr Sylvia Gandossi
Vice President, Australian Infection Control Association. Infection
Control Consultant
Infection control practice in both the public
and private health sectors
A/Prof Tom
Gottlieb
Senior specialist in microbiology and infectious diseases
Microbiology, infectious diseases
Mr Brett Mitchell
Director, Tasmanian Infection Prevention and Control Unit,
Department of Health and Human Services
Infection prevention and control in Australia
and internationally
Assoc Prof Peter
Morris
Paediatrician, NT Clinical Studies School, Royal Darwin Hospital and
Menzies School of Health Research, Darwin
Indigenous health, evidence-based medicine
Department of Microbiology and Infectious Diseases, Concord
Hospital, NSW
'1'
Terms of Reference
The Infection Control Steering Committee (the Committee) will oversee and provide expertise in the revision of the Infection control guidelines for
the prevention of transmission of infectious disease in the health care setting (2004) (the Guidelines).
1. The revision will take into account but not be limited to:
The current Infection control guidelines for the prevention of transmission of infectious disease in the health care setting (2004) produced by the
CDNA
The best available current scientific evidence
NHMRC recommended standards on guideline development
Comments provided by the broader community and health care sector through feedback from the project’s stakeholder group,
targeted consultations and public consultation
2. The Committee will provide advice on the following areas of the Guidelines revision:
The scope and requirements of the systematic review
The formulation of recommendations from the results of the systematic review
The content of the Guidelines
The development of educational materials and companion documents
Identification of indicators for the purpose of evaluation and monitoring the guidelines implementation
The development of an implementation strategy; and
Key stakeholders to undertake liaison/consultation
3. The Committee will provide regular reports on the progress of guideline development to the CEO of the NHMRC
4. The Committee will provide the NHMRC CEO with a draft report for the CEO to seek advice from Council.
Source URL (modified on 05/05/2011 - 09:53): https://www.nhmrc.gov.au/book/australian-guidelines-prevention-and-control-infectionhealthcare-2010/appendix-1-membership-an
'2'